Note this is called '1% solution' rather than 'ear drops'.
Gentamicin 0.3% Ear drops (Genticin®)
Formulary
12.01.01
Other aural preparations
....
Non Formulary Items
Acetic Acid 5% solution in IMS
Non Formulary
Betamethasone Sodium Phosphate with Antibacterial (Vista-Methasone N®)
Non Formulary
Hydrocortisone with Antibacterial (Neo-Cortef®)
Non Formulary
Hydrocortisone with Antibactrial (Otosporin®)
Non Formulary
Discontinued and removed from BNF 2014.
Neomycin Sulphate with corticosteroids (Neo-Cortef®)
Non Formulary
Neomycin Sulphate with corticosteroids (Otosporin®)
Non Formulary
Discontinued and removed from BNF 2014.
Prednisolone 0.5% with Neomycin 0.5% (Predsol-N®)
Non Formulary
Discontinued in 2011.
Triamcinolone with antibacterial (Otocomb Otic®)
Non Formulary
Triamcinolone with Antibacterial (Tri-Adcortyl Otic®)
Non Formulary
Discontinued in November 2008.
Key
Notes
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Restricted Drug
Unlicensed
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Scottish Medicines Consortium
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
CCG
Traffic Light Status Information
Status
Description
Red: Medicines which should only be prescribed in secondary care by a specialist.
Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.
Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).
Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.
Brown: Medicines which should only be prescribed in restricted circumstances.
Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.